These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33068839)

  • 1. The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wu R; An DA; Shi RY; Chen BH; Wu CW; Jiang M; Xu JR; Wu LM; Pu J
    Eur J Radiol; 2020 Nov; 132():109333. PubMed ID: 33068839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.
    Nguyen C; Lu M; Fan Z; Bi X; Kellman P; Zhao S; Li D
    J Cardiovasc Magn Reson; 2015 Dec; 17():107. PubMed ID: 26631061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular Dysfunction Associates With Outcomes in Hypertrophic Cardiomyopathy: Insights From the Intravoxel Incoherent Motion MRI.
    Xiang X; Lin X; Zhang B; Lin C; Lei J; Guo S; Zhao S
    J Magn Reson Imaging; 2023 Jun; 57(6):1766-1775. PubMed ID: 36200627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
    Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
    Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of intravoxel incoherent motion diffusion-weighted imaging in the assessment of the dynamic status of myocardial perfusion.
    An DA; Chen BH; Rui-Wu ; Shi RY; Bu J; Ge H; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Dec; 48(6):1602-1609. PubMed ID: 29734489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Thompson EW; Kamesh Iyer S; Solomon MP; Li Z; Zhang Q; Piechnik S; Werys K; Swago S; Moon BF; Rodgers ZB; Hall A; Kumar R; Reza N; Kim J; Jamil A; Desjardins B; Litt H; Owens A; Witschey WRT; Han Y
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):120. PubMed ID: 34689798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
    Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
    Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):18. PubMed ID: 33658040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
    Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
    J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.
    Małek ŁA; Werys K; Kłopotowski M; Śpiewak M; Miłosz-Wieczorek B; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Marczak M; Witkowski A
    Magn Reson Imaging; 2015 Jul; 33(6):718-24. PubMed ID: 25863138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement.
    Shi RY; An DA; Chen BH; Wu R; Du L; Jiang M; Xu JR; Wu LM
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2229-2238. PubMed ID: 32666169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
    Kellman P; Wilson JR; Xue H; Bandettini WP; Shanbhag SM; Druey KM; Ugander M; Arai AE
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):64. PubMed ID: 22967246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
    Xu J; Zhuang B; Sirajuddin A; Li S; Huang J; Yin G; Song L; Jiang Y; Zhao S; Lu M
    Radiology; 2020 Feb; 294(2):275-286. PubMed ID: 31769741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.